Arca
Skip to content

Sentinol Nitinol Billary Stent System

Stents, Drains And Dilators For The Biliary Ducts. 510(k) K032025, from Boston Scientific Corp (Maple Grove, MN). Product code FGE, class 2.

As of Nov 17, 2026, K032025 is an FDA 510(k) held by Boston Scientific Corp, substantially equivalent on Sep 25, 2003 after 87 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Sep 25, 2003
  • Review time: 87 days
  • Recalls: 1
  • Cited as a predicate by: 1 device

Cited as a Predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K032025, newest first; each opens FDA's recall record
StartedReasonStatus
May 14, 2004Z-0440-06One lot of one catalog number of the Sentinol Nitinol Biliary Stent System may have been packaged in a Sentinol nitinol Vascular outer carton. The product, pouch label and carton label are all correct and the correct…Terminated

Other FGE Clearances

The newest 510(k)s for the same product code; their median review was 162 days; see every FGE device

Record

Type
Traditional
Received
Jun 30, 2003
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.5010

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.